[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$fyptuzzgc62yw":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":13,"approvalsBeforeLoe":23,"products":24,"patents":79,"exclusivities":80,"paragraphIv":81,"catalysts":83},"THYRO-TABS","LEVOTHYROXINE SODIUM","ALVOGEN","alvogen",[20],"021116","none",12,0,[25,34,38,42,46,50,54,58,62,66,70,74],{"key":26,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-001","001","TABLET","ORAL","0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","2002-10-24","AB1,AB2,AB3,AB4","RX",{"key":35,"applNo":20,"productNo":36,"dosageForm":28,"route":29,"strength":37,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-002","002","0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",{"key":39,"applNo":20,"productNo":40,"dosageForm":28,"route":29,"strength":41,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-003","003","0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",{"key":43,"applNo":20,"productNo":44,"dosageForm":28,"route":29,"strength":45,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-004","004","0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",{"key":47,"applNo":20,"productNo":48,"dosageForm":28,"route":29,"strength":49,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-005","005","0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",{"key":51,"applNo":20,"productNo":52,"dosageForm":28,"route":29,"strength":53,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-006","006","0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",{"key":55,"applNo":20,"productNo":56,"dosageForm":28,"route":29,"strength":57,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-007","007","0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",{"key":59,"applNo":20,"productNo":60,"dosageForm":28,"route":29,"strength":61,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-008","008","0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",{"key":63,"applNo":20,"productNo":64,"dosageForm":28,"route":29,"strength":65,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-009","009","0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",{"key":67,"applNo":20,"productNo":68,"dosageForm":28,"route":29,"strength":69,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-010","010","0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",{"key":71,"applNo":20,"productNo":72,"dosageForm":28,"route":29,"strength":73,"approvalDate":31,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-011","011","0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",{"key":75,"applNo":20,"productNo":76,"dosageForm":28,"route":29,"strength":77,"approvalDate":78,"rld":4,"teCode":32,"type":33,"loe":12,"basis":21,"carveOutPossible":13},"021116-012","012","0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","2004-12-07",[],[],{"asOf":12,"firstFiled":12,"entries":82},[],[]]